(Q44366527)

2 December 2017

Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides (English)

1 reference

2 December 2017

1 reference

ChEBI release 2020-05-28

5

1 reference

2 December 2017

7

Claudiu T Supuran

1 reference

2 December 2017

Daniela Vullo

1

1 reference

2 December 2017

Marco Franchi

2

1 reference

2 December 2017

Enzo Gallori

3

1 reference

2 December 2017

Jaromir Pastorek

4

1 reference

2 December 2017

Silvia Pastorekova

6

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

2 December 2017

5

1 reference

Bioorganic & Medicinal Chemistry Letters

inferred from page(s)

published in

1 reference

2 December 2017

13

1 reference

2 December 2017

1005-1009

1 reference

2 December 2017

6

1 reference

Applications of carbonic anhydrase inhibitors and activators in therapy

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900091-X

7 January 2021

Carbonic anhydrase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900091-X

7 January 2021

Cloning, expression and some properties of alpha-carbonic anhydrase from Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900091-X

7 January 2021

Characterisation of carbonic anhydrase in Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900091-X

7 January 2021

Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900091-X

7 January 2021

Carbonic anhydrase IX, MN/CA IX: analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900091-X

7 January 2021

The catalytic properties of human carbonic anhydrase IX

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900091-X

7 January 2021

Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900091-X

7 January 2021

MN antigen expression in normal, preneoplastic, and neoplastic esophagus: a clinicopathological study of a new cancer-associated biomarker

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900091-X

7 January 2021

Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900091-X

7 January 2021

Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900091-X

7 January 2021

Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900091-X

7 January 2021

The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900091-X

7 January 2021

Expression of carbonic anhydrase IX in breast is associated with malignant tissues and is related to overexpression of c-erbB2.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900091-X

7 January 2021

Causes and consequences of tumour acidity and implications for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900091-X

7 January 2021

Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900091-X

7 January 2021

Carbonic anhydrase inhibitors: synthesis of N-morpholylthiocarbonylsulfenylamino aromatic/heterocyclic sulfonamides and their interaction with isozymes I, II and IV.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900091-X

7 January 2021

Carbonic anhydrase inhibitors: aromatic sulfonamides and disulfonamides act as efficient tumor growth inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900091-X

7 January 2021

Carbonic anhydrase inhibitors - Part 94. 1,3,4-Thiadiazole-2-sulfonamide derivatives as antitumor agents?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900091-X

7 January 2021

Carbonic anhydrase inhibitors: sulfonamides as antitumor agents?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900091-X

7 January 2021

Carbonic anhydrase inhibitors — Part 29 1: Interaction of isozymes I, II and IV with benzolamide-like derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900091-X

7 January 2021

Carbonic Anhydrase Inhibitors. Synthesis of Water-Soluble, Topically Effective, Intraocular Pressure-Lowering Aromatic/Heterocyclic Sulfonamides Containing Cationic or Anionic Moieties: Is the Tail More Important than the Ring?1

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900091-X

7 January 2021

10.1016/S0960-894X(03)00091-X

Identifiers

DOI

1 reference

2 December 2017

1 reference